Search
for
Sort by
Research 61–90 of 73
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
- Trichotillomania: What Do We Know So Far?
- Quality of life in Romanian patients with schizophrenia based on gender, type of schizophrenia, therapeutic approach, and family history
- Clinical and Molecular Genetic Findings of Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- A Case of Delusional Parasitosis Secondary to Severe Iron Deficiency Anaemia in a Tertiary Care Hospital: An Area for Clinical Vigilance
- “Doctor, You Must Examine My Creature Collection!”: A Case Report of Delusional Infestation
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks
- <i>C2orf37</i> mutational spectrum in Woodhouse–Sakati syndrome patients
- Coats' Plus: A Progressive Familial Syndrome of Bilateral Coats' Disease, Characteristic Cerebral Calcification, Leukoencephalopathy, Slow Pre- and Post-Natal Linear Growth and Defects of Bone Marrow and Integument
- Drugs that affect autonomic functions or the extrapyramidal system
- To grow or not to grow: Hair morphogenesis and human genetic hair disorders
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Woodhouse-Sakati Syndrome with Unique Unreported Previous Findings
- Woodhouse-Sakati syndrome: genotype–phenotype review and case of intra-familial heterogeneity
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- How to diagnose a lipodystrophy syndrome
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Psychocutaneous disease
- Psychodermatology
- Expansion of the spectrum of ITGB6-related disorders to adolescent alopecia, dentogingival abnormalities and intellectual disability
- Association Between Human Hair Loss and the Expression Levels of Nucleolin, Nucleophosmin, and<i>UBTF</i>Genes
- Reporting on Adverse Clinical Events
- Pediatric Psychocutaneous Disorders
- Psychotropic Medications and the Skin